EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Timing of postoperative radiation therapy for major salivary gland cancers

Flora Yan, Jeffrey C Liu iD, Rebecca Shulman, Thomas J Galloway iD, John A Ridge, Christopher M K L Yao

Head & Neck · 2024

DOI: 10.1002/hed.27845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Flora Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Carcinoma, Mucoepidermoid. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of timing of PORT initiation for major salivary gland cancers on survival is unknown. We aim to examine the impact of PORT timeliness on overall survival (OS) of patients with major salivary gland cancers.

Methods

This was a cross‐sectional analysis using data from the National Cancer Database (2004–2017) and included patients with major salivary gland cancer treated with surgery and PORT.

Results

In total, 5701 patients were included (3133 [55%] male, 4644 [82%] white, mean age 59 ± 16 years). For the overall cohort, PORT >6 weeks was not associated with decreased OS (1.00 aHR, 95% CI 0.89–1.11). When specifically examining patients with mucoepidermoid carcinoma, PORT >6 weeks was associated with a decreased OS (1.27 aHR, 95% CI 1.01–1.58).

Conclusions

Overall, this analysis did not demonstrate a survival benefit for initiating PORT within 6 weeks for patients with salivary gland malignancies. Subset analysis did support initiating PORT within 6 weeks after resection for patients with mucoepidermoid carcinomas. This was not demonstrated in other major salivary gland cancer histologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsCarcinoma, MucoepidermoidHumansMaleMiddle AgedFemaleCross-Sectional StudiesAgedAdultRadiotherapy, AdjuvantTime FactorsDatabases, FactualSurvival RateTime-to-TreatmentUnited StatesRetrospective Studies

Stichwörter der Autor:innen

adjuvant treatmentradiation therapysalivary gland cancersalivary gland carcinomastimely treatment

Autor:innen und Institutionen

  • Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • Division of Head and Neck Surgery, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology - Head & Neck Surgery, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Jeffrey C Liu, Thomas J Galloway

Zitieren

APA

Yan, F., Liu, J. C., Shulman, R., Galloway, T. J., Ridge, J. A., & Yao, C. M. K. L. (2024). Timing of postoperative radiation therapy for major salivary gland cancers. Head & Neck. https://doi.org/10.1002/hed.27845

Vancouver

Yan F, Liu JC, Shulman R, Galloway TJ, Ridge JA, Yao CMKL. Timing of postoperative radiation therapy for major salivary gland cancers. Head & Neck. 2024. doi:10.1002/hed.27845

BibTeX
@article{Yan2024,
  author = {Yan, Flora and Liu, Jeffrey C and Shulman, Rebecca and Galloway, Thomas J and Ridge, John A and Yao, Christopher M K L},
  title = {Timing of postoperative radiation therapy for major salivary gland cancers},
  journal = {Head & Neck},
  year = {2024},
  doi = {10.1002/hed.27845}
}
Kostenlos starten →